Physician profile
Jerry J Lorio
NPI 1336123512
$3,441.93
in general payments reported to CMS, 2019-2025
22 companies · $738 in 2025
The $738 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $134 · 2021: $424 · 2022: $568 · 2023: $304 · 2024: $860 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336 · Education: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,335.64 |
| Education | $566.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,496.39 | 2019-2025 | Comprehensive Shoulder System, Persona |
| Radius Health, INC. | $354.65 | 2019-2025 | Tymlos |
| Smith+Nephew, INC. | $205.19 | 2019-2024 | Stravix |
| Stryker Corporation | $201.66 | 2025 | Gamma |
| Djo, LLC | $198.10 | 2021-2025 | Cmf |
| Horizon Therapeutics Plc | $173.63 | 2019-2022 | |
| Mentor Worldwide LLC | $130.96 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Solventum Corporation | $119.82 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Innovation Technologies INC | $98.49 | 2022-2024 | Irrisept |
| Heron Therapeutics, INC. | $94.88 | 2024-2025 | Zynrelef |
| Bioventus LLC | $82.82 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $46.24 | 2022-2023 | Iovera |
| Vertex Pharmaceuticals Incorporated | $42.34 | 2024-2025 | |
| Anika Therapeutics, INC. | $35.84 | 2023 | Tactoset |
| Baudax Bio INC. | $34.39 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $22.65 | 2025 | Via Matrix |
| Treace Medical Concepts, INC. | $20.08 | 2024 | |
| Polynovo North America LLC | $18.46 | 2024 | Novosorb Btm |
| Globus Medical, INC. | $18.18 | 2025 | Omnia |
| Depuy Synthes Sales INC. | $17.17 | 2021 | |
| Amgen INC. | $15.90 | 2022 | |
| Orthalign INC | $14.09 | 2024 | Orthalign Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Lorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.